RUBINO, TIZIANA
 Distribuzione geografica
Continente #
NA - Nord America 10.447
EU - Europa 6.157
AS - Asia 2.920
SA - Sud America 450
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 3
Totale 20.023
Nazione #
US - Stati Uniti d'America 10.312
IT - Italia 3.267
SG - Singapore 1.041
UA - Ucraina 926
SE - Svezia 565
CN - Cina 494
TR - Turchia 452
BR - Brasile 388
HK - Hong Kong 379
VN - Vietnam 368
DE - Germania 268
FI - Finlandia 252
IE - Irlanda 241
GB - Regno Unito 225
RU - Federazione Russa 129
CA - Canada 76
FR - Francia 76
MX - Messico 47
JP - Giappone 46
NL - Olanda 46
IN - India 36
PL - Polonia 32
BE - Belgio 27
CZ - Repubblica Ceca 26
AR - Argentina 18
BD - Bangladesh 18
ZA - Sudafrica 17
IQ - Iraq 16
ES - Italia 15
EU - Europa 11
CL - Cile 10
CH - Svizzera 9
VE - Venezuela 9
AT - Austria 8
CO - Colombia 7
PK - Pakistan 7
SA - Arabia Saudita 7
BG - Bulgaria 6
LT - Lituania 6
MY - Malesia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
ID - Indonesia 5
MA - Marocco 5
NP - Nepal 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
IL - Israele 4
MD - Moldavia 4
PE - Perù 4
PT - Portogallo 4
PY - Paraguay 4
JO - Giordania 3
KR - Corea 3
KZ - Kazakistan 3
NG - Nigeria 3
NO - Norvegia 3
PH - Filippine 3
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
EG - Egitto 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
PA - Panama 2
PS - Palestinian Territory 2
SM - San Marino 2
TN - Tunisia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DZ - Algeria 1
ET - Etiopia 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NZ - Nuova Zelanda 1
OM - Oman 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 20.023
Città #
Milan 2.024
Fairfield 1.355
Woodbridge 851
Ashburn 841
Chandler 755
Jacksonville 711
Houston 676
Seattle 586
Singapore 565
Ann Arbor 534
Wilmington 510
Cambridge 467
Hong Kong 378
Dearborn 272
Princeton 257
Nyköping 248
Dublin 240
Izmir 222
Dallas 207
Beijing 191
Boardman 180
Como 176
Rome 161
New York 156
Dong Ket 142
The Dalles 132
San Mateo 93
Los Angeles 84
Chicago 74
San Diego 71
London 55
Santa Clara 46
Tokyo 45
Ogden 44
Munich 39
São Paulo 39
Washington 39
Toronto 36
Warsaw 31
Mexico City 30
Norwalk 30
Helsinki 29
Ho Chi Minh City 29
Hefei 27
Brussels 25
Brno 24
Hanoi 22
Kunming 22
Ponte Lambro 22
Nanjing 21
Montreal 20
Denver 18
Orem 18
Verona 18
Mcallen 17
Atlanta 16
Brooklyn 16
Turin 16
Kocaeli 15
Phoenix 15
Carbonara Al Ticino 14
Chennai 14
Nanchang 14
Poplar 14
Stockholm 14
Amsterdam 13
Berlin 13
Varese 13
Manchester 12
Redwood City 12
San Francisco 12
Guangzhou 11
Jinan 11
Johannesburg 11
Naples 11
Ankara 10
Brasília 9
Council Bluffs 9
Düsseldorf 9
Frankfurt am Main 9
Nuremberg 9
Rio de Janeiro 9
Shanghai 9
Boston 8
Istanbul 8
Ottawa 8
Redmond 8
Turku 8
Auburn Hills 7
Bologna 7
Cagliari 7
Cairate 7
Edinburgh 7
Falls Church 7
Fuzhou 7
Gallarate 7
Gavirate 7
Palermo 7
Paris 7
Chongqing 6
Totale 14.368
Nome #
Cannabinoidi ed ansia: meccanismi cellulari/molecolari e ruolo degli endocannabinoidi nella modulazione degli stati ansiosi 340
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 295
Correlati cellulari e molecolari dell'abuso di Salvia divinorum: ruolo dei recettori cannabici e k oppioidi 275
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect 269
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats 265
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex 254
Assay of GTPγS binding in autoradiography 247
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice 247
Adolescent exposure to cannabis as a risk factor for psychiatric disorders 244
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2 240
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine 237
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex 230
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin 223
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour 215
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol. 215
A molecular basis of analgesic tolerance to cannabinoids 213
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats. 213
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism 210
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 208
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence. 207
New vistas on cannabis use disorder 205
Long lasting consequences of cannabis exposure in adolescence. 204
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling 199
Endocannabinoids and Mental Disorders. 197
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats 193
Cannabinoids and opioids share cAMP pathway in rat splenocytes 192
Chronic Delta(9)-THC Exposure Differently Affects Histone Modifications in the Adolescent and Adult Rat Brain 190
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine 188
Role of endocannabinoids in regulating drug dependence 186
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring 186
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. 186
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 185
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 183
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT? 181
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors. 181
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. 179
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. 175
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models 174
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect. 174
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex 174
Cannabinoids and Drugs of abuse 173
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. 171
Cellular mechanisms underlying the interaction between cannabinoid and opioid system 170
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain 169
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 169
The endocannabinoid system and schizophrenia: integration of evidence. 169
Modulation of rat brain cannabinoid receptors after chronic morphine treatment 168
Endocannabinoids and Drug Dependence 167
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. 166
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain 163
Molecular and cellular basis of cannabinoid and opioid interactions 163
Sex-dependent vulnerability to cannabis abuse in adolescence 163
Endocannabinoids in the immune system and cancer 162
The endocannabinoid system and psychiatric disorders. 162
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940 160
Neurobiological mechanisms underlying cannabis-induced memory impairment 157
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments 156
The psychoactive ingredient of marijuana induces behavioural sensitization 153
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems 153
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats 153
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects 152
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade 151
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure 148
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system 148
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251. 147
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. 146
Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. 145
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages 141
Presence of a reduced opioid response in interleukin-6 knock out mice 140
Termination of acute stress response by the endocannabinoid system is regulated through LSD1-mediated transcriptional repression of 2-AG hydrolases ABHD6 and MAGL 139
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models 138
Uso di Cannabis in adolescenza come fattore di rischio per malattie psichiatriche e dipendenza da altre sostanze 137
Cellular mechanisms of Delta(9)-tetrahydrocannabinol behavioural sensitization 136
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line 133
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas. 133
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors 132
null 132
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models 131
Further investigations on the antipropulsive effect of centrally administered histamine and its relation with morphine. 129
Modulation of extracellular signal-regulated kinases cascade by cronic Delta(99-tetrahydrocannabinol treatment 129
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study. 128
Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression. 126
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats. 126
Is cannabinoid transmission involved in rewarding properties of drugs of abuse 123
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition. 123
Pertussis toxin modifies the effect of central morphine on rat intestinal motility. 123
Ruolo emergente dei meccanismi epigenetici e della neuroinfiammazione nei disturbi associate al consume di cannabis 123
CB1 cannabinoid and mu opioid receptors density and functionality are altered in rats self-administering either heroin or the CB1 receptor agonist WIN 55,212-2 122
Bombesin receptor antagonist. 2. Analogues based on substance P antagonists 120
Pertussis toxin pretreatment affects opiate/nonopiate and stress-induced analgesia differently. 119
Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood 118
ERK-dependent modulation of cerebellar synaptic plasticity after chronic Delta 9-tetrahydrocannabinol exposure 116
Behavioral, proteomic and lipidomic analyses in adult male and female rats exposed to cannabinoids during adolescence: an integrative approach to identify markers of vulnerability for psychiatric disorders and drug abuse 116
Studio sperimentale dell'interazione tra abuso di steroidi anabolizzanti e cannabinoidi nella depressione: dall'analisi comportamentale ai substrati cellulari 116
Adolescent drug exposure: A review of evidence for the development of persistent changes in brain function 115
Dos(e)Age: Role of Dose and Age in the Long-Term Effect of Cannabinoids on Cognition 115
Il sistema endocannabinoide 113
Presence of a reduced opioid response in interleukin-6 knock out mice. 113
Cholera toxin antagonizes morphine-induced catalepsy through a cyclic AMP-independent mechanism. 110
PLOS One 108
Totale 17.006
Categoria #
all - tutte 78.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.593 0 0 0 0 0 263 122 167 341 139 229 332
2021/20221.413 144 162 114 183 52 61 61 73 59 209 121 174
2022/20231.951 188 132 123 257 97 417 2 272 249 72 107 35
2023/20243.372 505 534 514 580 623 302 17 69 70 53 36 69
2024/20252.221 43 47 356 91 70 160 112 156 286 195 175 530
2025/20262.226 374 323 157 654 476 242 0 0 0 0 0 0
Totale 20.181